Axogen (AXGN) Change in Accured Expenses (2010 - 2026)
Axogen's (AXGN) quarterly Change in Accured Expenses came in at $2.2 million in Q1 2026, up 124.21% year-on-year from $980332.2 in Q1 2025, and up 1291.14% quarter-over-quarter from $158000.0 in Q4 2025.
Axogen (AXGN) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Axogen's Change in Accured Expenses history runs 17 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- On a quarterly basis, Change in Accured Expenses rose 124.21% year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was $11.3 million, a 930.21% increase from a year earlier, with the FY2025 full-year figure at $47000.0, down 88.92% from the prior year.
- Change in Accured Expenses grew to $2.2 million in Q1 2026 per AXGN's latest filing, from $158000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $7.1 million in Q3 2024 and bottomed at -$9.1 million in Q1 2025.
- The 5-year median for Change in Accured Expenses is $714000.0 (2024), against an average of $578705.9.
- Across the five-year window, Change in Accured Expenses jumped 4315.48% in 2023 and slumped 198.57% in 2024, its largest moves.
- Year by year, Change in Accured Expenses stood at $1.5 million in 2022, then surged by 128.56% to $3.5 million in 2023, then sank by 102.03% to -$71000.0 in 2024, then jumped by 322.54% to $158000.0 in 2025, then surged by 1291.14% to $2.2 million in 2026.
- Per Business Quant, the three latest AXGN Change in Accured Expenses figures stand at $2.2 million (Q1 2026), $158000.0 (Q4 2025), and $5.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.80 Bn | 176.50 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.84 Bn | 125.96 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 68.51 Bn | 67.06 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 48.18 Bn | 44.51 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | 145.10 Mn |
| 7 | GE HealthCare Technologies | 28.16 Bn | 25.88 Bn | 1.98 Bn | -250.00 Mn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn | 21.07 Mn |
| 10 | Axogen | 2.11 Bn | 2.00 Bn | 46.19 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.20 Mn |
| Mar 31, 2026 | 2.20 Mn |
| Dec 31, 2025 | 158,000.00 |
| Dec 31, 2025 | 158,000.00 |
| Sep 30, 2025 | 5.64 Mn |
| Sep 30, 2025 | 5.64 Mn |
| Jun 30, 2025 | 3.32 Mn |
| Jun 30, 2025 | 3.32 Mn |
| Mar 31, 2025 | -9.08 Mn |
| Mar 31, 2025 | -9.08 Mn |
| Dec 31, 2024 | -71,000.00 |
| Dec 31, 2024 | -71,000.00 |
| Sep 30, 2024 | 7.07 Mn |
| Sep 30, 2024 | 7.07 Mn |
| Jun 30, 2024 | 714,000.00 |
| Jun 30, 2024 | 714,000.00 |
| Mar 31, 2024 | -7.29 Mn |
| Mar 31, 2024 | -7.29 Mn |
| Dec 31, 2023 | 3.50 Mn |
| Dec 31, 2023 | 3.50 Mn |